[心脏外科手术中抗血栓保护的历史]
Z A Kavteladze1, P M Ermolaev1, S Yu Danilenko1
1Petrovsky National Research Center of Surgery, Moscow, Russia.
Khirurgiia
|December 12, 2024
概括
抗栓塞性保护系统,特别是对于脑栓塞,在心脏和内血管外科手术中至关重要. 预防这些危险的并发症可以改善心血管程序中的患者结果.
科学领域:
- 心血管外科心血管外科
- 神经学 神经学
- 医疗器械技术 医疗器械技术
背景情况:
- 脑栓塞是心血管外科手术中经常发生的严重并发症.
- 这种并发症可能会导致患者的严重残疾和较差的治疗结果.
- 有效的预防策略对于改善外科手术结果至关重要.
研究的目的:
- 审查抗血栓保护系统的历史发展.
- 专注于旨在预防心脏和内血管程序期间脑栓塞的系统.
- 为了突出血栓并发症预防在心脏门疾病纠正中的重要性.
主要方法:
- 对抗血栓保护的历史和当前实践的文献综述.
- 分析心脏和内血管外科手术中脑栓塞的发生率和影响.
- 检查栓保护装置的技术进步.
主要成果:
- 抗栓塞性保护系统的发展是由减轻神经损伤的需要驱动的.
- 大脑保护策略越来越多地被整合到复杂的心血管干预中.
- 技术创新继续提高预防栓塞事件的有效性.
结论:
- 抗栓塞性保护对于改善心脏和内血管外科手术患者安全和结果至关重要.
- 对栓塞性保护系统的持续研究和开发是必要的.
- 预防脑栓塞仍然是现代心血管干预的关键目标.
相关概念视频
01:20Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
468
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
468
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
616
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
616